The general population has less than a 20 percent chance of developing breast cancer. However, for a person who tests positive for a gene mutation linked to breast cancer, the risk goes up to 87 ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

A genetic risk score could one day guide more personalized treatment for high-risk women, while sparing low-risk women from unnecessary procedures. A new genetic analysis could help predict whether ...

Please provide your email address to receive an email when new articles are posted on . Breast Cancer Awareness Month is observed every October. The campaign is designed to increase awareness of the ...

Advancements in technology, testing and imaging have transformed cancer detection and risk assessment, enabling them to be faster and more precise. But providing patients with a cancer risk score or ...

Regeneron Pharmaceuticals said Monday it will buy genetic testing company 23andMe out of bankruptcy for $256 million, a deal that provides the US biotech company with data on millions of clients.

Before Todd Leach lost his father to a rare, aggressive form of stomach cancer, his dad gave him one last gift: a genetic test. It was then that Leach, of Cabot, Arkansas, learned his father carried a ...